共 737 条
- [1] Braun TP(2020)Response and resistance to BCR–ABL1-targeted therapies Cancer Cell 37 530-542
- [2] Eide CA(2019)Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy J Hematol Oncol 12 134-196
- [3] Druker BJ(2019)Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors incancer therapy J Hematol Oncol 12 27-458
- [4] Lim ZF(2018)Molecular targeted therapy: treating cancer with specificity Eur J Pharmacol 834 188-4067
- [5] Ma PC(2019)Targeting mTOR for cancer therapy J Hematol Oncol 12 71-64
- [6] Qin S(2014)The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment Cancers 6 436-1912
- [7] Li A(2012)The cyclic AMP pathway Cold Spring Harb Perspect Biol 4 a011148-354
- [8] Yi M(2020)What turns CREB on? And off? And why does it matter? Cell Mol Life Sci 77 4049-41
- [9] Yu S(2002)Reinventing the wheel of cyclic AMP: novel mechanisms of cAMP signaling Ann NY Acad Sci 968 49-3732
- [10] Zhang M(2013)Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion Diabetes 62 1904-15926